Globus Medical

At a glance

Globus Medical reported 2025 revenue of $2.94B, up 16.7% from $2.52B in 2024. Over 4 years since 2021 ($958.1M), that is growth of about 32.3% a year. Operating margin was 16.3%, down from 17.9% in 2021. 2025 was the highest revenue year in this period.

In the last 12 months 7 insiders reported 0 open-market purchases and 13 sales ($17.5M). 8 of the sales were made under pre-arranged 10b5-1 plans. The largest was a sale of $2.2M by Director James R Tobin on Sep 16, 2026.

Globus Medical filed 7 current reports (Form 8-K) in the last 12 months, most often for results of operations (5), officer or director change (2) and shareholder vote results (1). The latest officer or director change was reported on Jun 4, 2026.

2 of the 20 investors tracked here held Globus Medical at the last quarter end, worth $43.4M combined. It is the largest weight for Bridgewater Associates (0.1% of its portfolio), followed by Renaissance Technologies (0%). New this quarter: Renaissance Technologies. Added: Bridgewater Associates.

Annual results

Fiscal year ends Dec 31 · incorporated in DE

Tracked investors holding (13F)

Weight is the share of each investor's portfolio, as of the quarter end.